Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Tomin Perea-Chamblee, Kodi Taraszka, Habib El‐Khoury, Muhieddine Labban, Christopher J. Fong, Kanika Arora, Chris Labaki, Wenxin Xu, Guru Sonpavde, Robert I. Haddad, Kent W. Mouw, Marios Giannakis, F. Stephen Hodi, Noah Zaitlen, Adam J. Schoenfeld, Nikolaus Schultz, Michael F. Berger, Laura E. MacConaill, Guruprasad Ananda, David J. Kwiatkowski, Toni K. Choueiri, Deborah Schrag, Jian Carrot‐Zhang, Alexander Gusev
Topics & Concepts
PembrolizumabPrecision medicineBiomarkerGermlineCancerLung cancerMicrosatellite instabilityImmune checkpointOncologyMedicineBiologyImmunotherapyCancer researchInternal medicineGeneticsAlleleGeneMicrosatelliteCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research